» Articles » PMID: 6686962

A Comparison of the Content and Immunohistochemical Patterns of CEA-like Activity in Human Colorectal Tumours and Nude Mouse Xenografts

Overview
Journal Exp Pathol
Specialty Pathology
Date 1983 Jan 1
PMID 6686962
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The immunohistochemical pattern of CEA-like material was examined in sections of five human colonic tumour xenograft lines in nude mice and in the primary tumours from which these lines were derived. Conventional tissue sections were stained by a PAP immunoperoxidase technique, using affinity purified goat anti-CEA as the primary reagent. Normal human and nude mouse tissues were also examined. Saline extracts were made from three of the human tumours and from examples of the respective xenograft lines. The CEA content of extracts was determined by radioimmunoassay. The pattern of CEA-like material was similar in primary tumours and xenografts, but in 3/5 xenograft lines the intensity of specific staining was reduced when compared to that of the respective primary tumour. The three xenograft lines from which extracts were made contained mean values of 22%, 63% and 68% of the CEA activity found in the respective primary tumours, and the data suggested that reduced immunoperoxidase stain intensity seen in some xenografts resulted from the presence of far less antigen than in the corresponding primary tumour. We suggest that some xenograft lines represent subpopulations of cells in the primary tumour which produce less CEA than those of the primary tumour sample examined, although histologically no differences can be identified. No CEA-like activity was detected in normal nude mouse tissues.

Citing Articles

Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody.

Corvalan J, Smith W, Gore V, Brandon D, Ryde P Cancer Immunol Immunother. 1987; 24(2):138-43.

PMID: 3829048 PMC: 11038770. DOI: 10.1007/BF00205591.


Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

Corvalan J, Smith W, Gore V, Brandon D Cancer Immunol Immunother. 1987; 24(2):133-7.

PMID: 3829047 PMC: 11038282. DOI: 10.1007/BF00205590.


Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft.

Pedley R, Boden J, Keep P, Harwood P, Green A, Rogers G Eur J Nucl Med. 1987; 13(4):197-202.

PMID: 3040415 DOI: 10.1007/BF00256491.


Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.

Harwood P, Pedley R, Boden J, Rawlins G, Pentycross C, Rogers G Br J Cancer. 1985; 52(5):797-9.

PMID: 2998427 PMC: 1977225. DOI: 10.1038/bjc.1985.261.


The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.

Pedley R, Boden J, BODEN R, Green A, Boxer G, Bagshawe K Br J Cancer. 1989; 60(4):549-54.

PMID: 2803924 PMC: 2247110. DOI: 10.1038/bjc.1989.311.